Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, p. annrheumdis-2022-222359, 2022
DOI: 10.1136/annrheumdis-2022-222359
Links
Tools
Response to: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé
Journal article published in 2022 by
Robert Bm Landewé 
,
Juergen Braun
,
Juergen Braun
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 